METiS Therapeutics Funding: $252M Raised, Series A (2021)
METiS Therapeutics is based in Beijing, China. It has raised $252M in total funding. Latest round: Series A.
METiS Therapeutics funding overview
METiS Therapeutics is based in Beijing, China. METiS Therapeutics has raised $252M in total disclosed funding. That places its disclosed total in the $250M–$1B range. Its most recent disclosed round is a Series A announced in January 2021. The round record for METiS Therapeutics runs through 2021; nothing later has been disclosed. Investors on record include PICC PE, China Life, Sequoia Capital China, Lightspeed, 5Y Capital, Frees Fund Capital and 3 others. 9 distinct backers are named across the disclosed rounds.
METiS Therapeutics at a glance
Total raised
$252M
Latest round
Series A
Latest round date
January 2021
Headquarters
Beijing, China
Notable investors
PICC PE, China Life, Sequoia Capital China, Lightspeed, 5Y Capital, Frees Fund Capital, Sourcode Capital, XtalPi Inc.
Frequently asked about METiS Therapeutics funding
How much has METiS Therapeutics raised?
METiS Therapeutics has raised $252M in total disclosed funding across the rounds on record.
Who has invested in METiS Therapeutics?
PICC PE, China Life, Sequoia Capital China, Lightspeed, 5Y Capital, Frees Fund Capital are named among the investors backing METiS Therapeutics.
What was the latest METiS Therapeutics funding round?
The most recent disclosed round is a Series A, announced in January 2021.
Where is METiS Therapeutics based?
METiS Therapeutics is based in Beijing, China.
When did METiS Therapeutics last raise?
The last disclosed METiS Therapeutics round closed in January 2021 at Series A.
Round data for METiS Therapeutics is compiled from public filings and announcements; blank fields mean nothing has been disclosed rather than nothing exists. Continue with the companies in Beijing and backer lists below.
